+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation



The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation



Plos one 8(5): E63789



The P2X7 receptor binds extracellular ATP to mediate numerous inflammatory responses and is considered a potential biomarker and therapeutic target for diverse inflammatory and neurological diseases. P2X7 contains many single nucleotide polymorphisms, including several mutations located within its intracellular C-terminal trafficking domain. Mutations within the trafficking domain result in attenuated receptor activity and cell surface presentation, but the mechanisms by which amino acid changes within this region promote altered P2X7 function have not been elucidated. We analyzed the amino acid sequence of P2X7 for any potential trafficking signals and found that P2X7 contains putative Arg-X-Arg ER retention sequences. Alanine substitutions near or within these sequences were constructed, and we determined that single mutation of R574 and R578 but not R576 or K579 attenuates P2X7-stimulated activation of ERK1/2 and induction of the transcription factors FosB and ΔFosB. We found that mutation of R578 within the trafficking domain to the naturally occurring Gln substitution disrupts P2X7 localization at the plasma membrane and results in R578Q displaying a higher apparent molecular weight in comparison to wild-type receptor. We used the glycosidase endoglycosidase H to determine that this difference in mass is due in part to the R578Q mutant possessing a larger mass of oligosaccharides, indicative of improper N-linked glycosylation addition and/or trimming. Chemical cross-linking experiments were also performed and suggest that the R578Q variant also does not form trimers as well as wild-type receptor, a function required for its full activity. These data demonstrate the distal C-terminus of P2X7 is important for oligomerization and post-translational modification of the receptor, providing a mechanism by which mutations in the trafficking domain disrupt P2X7 activity and localization at the plasma membrane.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056170137

Download citation: RISBibTeXText

PMID: 23691096

DOI: 10.1371/journal.pone.0063789


Related references

Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. Biochemistry 49(22): 4611-4619, 2010

A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. Journal of Biological Chemistry 281(25): 17228-17237, 2006

The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Molecular Pharmacology 55(6): 1054-1059, 1999

A region of the C-terminal portion of the human transferrin receptor contains an asparagine-linked glycosylation site critical for receptor structure and function. Journal of Biological Chemistry 268(17): 12780-6, 1993

The N-terminus of Ramps is a critical determinant of the glycosylation state and ligand binding of calcitonin receptor-like receptor. Biochemical Society Transactions 27(4): 535-539, 1999

The N-terminus of RAMPs is a critical determinant of the glycosylation state and ligand binding of calcitonin receptor-like receptor. Biochemical Society Transactions 27(4): 535-539, 1999

Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Biochemistry 47(26): 6953-6968, 2008

P2X7-receptor-induced apoptosis of human cervical epithelial cells is mediated by increased calcium influx and depends on glycosylation status of the receptor. Drug Development Research 56(4): 561, 2002

Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Molecular Pharmacology 54(1): 22-32, 1998

Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. Journal of Immunology 171(3): 1304-1311, 2003

N-linked glycosylation of protease-activated receptor-1 second extracellular loop: a critical determinant for ligand-induced receptor activation and internalization. Journal of Biological Chemistry 285(24): 18781-18793, 2010

Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates. Journal of Nuclear Medicine 57(9): 1436-1441, 2016

Glycosylation sites encoded by exon 2 of the human insulin receptor gene are not required for the oligomerization, ligand binding, or kinase activity of the insulin receptor. Receptor 5(1): 71-80, 1995

Critical Role of a Subdomain of the N-Terminus of the V 1 a Vasopressin Receptor for Binding Agonists but Not Antagonists; Functional Rescue by the Oxytocin Receptor N-Terminus. Biochemistry 39(44): 13524-13533, 2000

Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; Functional rescue by the oxytocin receptor N-terminus. Biochemistry 39(44): 13524-13533, 2000